MOORE TIMOTHY L. has filed 12 insider transactions across 3 companies since April 2023.
Most recent transaction: a grant/award of 8170 shares of BIOLIFE SOLUTIONS INC ($BLFS) on February 24, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | BIOLIFE SOLUTIONS INC | $BLFS | MOORE TIMOTHY L. | Director | A | Common Stock | 8170 | $0.00 | 44,943.0000 | 48,723,535 | 22.22% | 0.02% |
| June 3, 2025 | CERUS CORP | $CERS | MOORE TIMOTHY L. | Not found | A | Common Stock | 60000 | $0.00 | 205,073.0000 | 185,789,815 | 41.36% | 0.03% |
| March 18, 2025 | BIOLIFE SOLUTIONS INC | $BLFS | MOORE TIMOTHY L. | Director | A | Common Stock | 6876 | $0.00 | 36,773.0000 | 46,067,073 | 23.00% | 0.01% |
| Feb. 3, 2025 | Allogene Therapeutics, Inc. | $ALLO | MOORE TIMOTHY L. | Chief Technical Officer | S | Common Stock | 14746 | $1.71 | 250,713.0000 | 0 | 5.55% | 0.00% |
| June 5, 2024 | CERUS CORP | $CERS | MOORE TIMOTHY L. | Director | A | Common Stock | 40000 | $5.00 | 145,073.0000 | 0 | 38.07% | 0.00% |
| April 22, 2024 | Allogene Therapeutics, Inc. | $ALLO | MOORE TIMOTHY L. | Chief Technical Officer | F | Common Stock | 17360 | $3.47 | 265,459.0000 | 0 | 6.14% | 0.00% |
| March 8, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | MOORE TIMOTHY L. | Director | A | Common Stock | 11264 | $0.00 | 29,897.0000 | 43,719,185 | 60.45% | 0.03% |
| Jan. 25, 2024 | Allogene Therapeutics, Inc. | $ALLO | MOORE TIMOTHY L. | Chief Technical Officer | A | Common Stock | 96600 | $0.00 | 282,819.0000 | 0 | 51.87% | 0.00% |
| Jan. 25, 2024 | Allogene Therapeutics, Inc. | $ALLO | MOORE TIMOTHY L. | Chief Technical Officer | A | Stock Option (Right to buy) | 341515 | $0.00 | 341,515.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | CERUS CORP | $CERS | MOORE TIMOTHY L. | Director | A | Common Stock | 40000 | $5.00 | 105,073.0000 | 0 | 61.47% | 0.00% |
| April 24, 2023 | Allogene Therapeutics, Inc. | $ALLO | MOORE TIMOTHY L. | Chief Technical Officer | A | Stock Option (Right to Buy) | 831024 | $0.00 | 831,024.0000 | 0 | 9999.99% | 0.00% |
| April 24, 2023 | Allogene Therapeutics, Inc. | $ALLO | MOORE TIMOTHY L. | Chief Technical Officer | A | Common Stock | 186219 | $0.00 | 186,219.0000 | 0 | 9999.99% | 0.00% |